ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Net margin 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) net profit margin by fiscal year — reported net income divided by reported revenue.
-0.2%FY2025 · since FY2016: -51614.6% → -0.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -0.2% | +16882.2 pp |
| FY2024 | -16882.4% | -16797.1 pp |
| FY2023 | -85.3% | -12.9 pp |
| FY2022 | -72.4% | +29.5 pp |
| FY2021 | -101.9% | -5.8 pp |
| FY2020 | -96.1% | -136.4 pp |
| FY2019 | 40.3% | +377.6 pp |
| FY2018 | -337.3% | -227.9 pp |
| FY2017 | -109.5% | +51505.2 pp |
| FY2016 | -51614.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARWR financial trends
ARWR RevenueARWR Net incomeARWR Gross profitARWR Gross marginARWR Operating incomeARWR Operating marginARWR Operating cash flowARWR Free cash flowARWR Capital expendituresARWR Return on equityARWR Stock buybacksARWR Dividends paidARWR Total assetsARWR Total liabilitiesARWR Shareholders’ equityARWR overview →